首页> 外文OA文献 >Stereoselectivity in the urinary excretion of the mercapturates of (R-) and (S-) alpha-bromoisovalerylurea in man.
【2h】

Stereoselectivity in the urinary excretion of the mercapturates of (R-) and (S-) alpha-bromoisovalerylurea in man.

机译:人体中(R-)和(S-)α-溴代异戊酸硫脲的尿排泄物中的立体选择性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. alpha-Bromoisovalerylurea (BIU) is a racemic drug that is metabolized by glutathione conjugation. The urinary excretion of the separate diastereomeric mercapturates formed from (S)- and (R)-BIU in healthy young human volunteers was investigated. 2. A pronounced stereoselectivity was observed: the mercapturate formed from R-BIU was excreted with a t1/2 of 1.5 +/- 0.4 h, while that from S-BIU showed a t1/2 of 3.1 +/- 1.3 h. Moreover, 22.5 +/- 4.3 and 5.7 +/- 1.6% of the dose, respectively, was excreted as each mercapturate diastereomer in 24 h. 3. This is the first example of stereoselectivity in the elimination of a substrate for glutathione conjugation in man.
机译:1.α-Bromoisovalerylurea(BIU)是一种外消旋药物,通过谷胱甘肽结合而代谢。研究了在健康的年轻人类志愿者中由(S)-和(R)-BIU形成的非对映异构巯基的尿排泄情况。 2.观察到明显的立体选择性:由R-BIU形成的巯基化物的t1 / 2为1.5 +/- 0.4 h,而从S-BIU形成的巯基的t1 / 2为3.1 +/- 1.3 h。此外,作为巯基非对映异构体,在24小时内分别排泄了22.5 +/- 4.3和5.7 +/- 1.6%的剂量。 3.这是消除人体内谷胱甘肽结合底物的立体选择性的第一个例子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号